Redmile Group, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$6,486,000
+12.1%
408,462
-7.7%
0.52%
-6.7%
Q2 2016$5,788,000
-87.8%
442,711
-89.8%
0.55%
-88.6%
Q1 2016$47,263,000
+11.1%
4,320,192
+17.7%
4.84%
+51.9%
Q4 2015$42,551,000
+2040.4%
3,671,344
+1824.3%
3.18%
+2008.6%
Q3 2015$1,988,000190,7890.15%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders